AMLX

Conviction 80HealthcareScan · Fri, Jun 26, 2026

AMLX$17.79+2.01%

ResistanceSupportVol 14Insider buy

Vol MA14 1.72M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Amylyx Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.amylyx.com ↗

Price17.79

Change+2.01%

Gap-0.09%

Rel volume0.98×

Avg volume1.62M

Avg $ vol24.33M

SMA 2014.86

SMA 5015.19

SMA 20014.23

Price vs 50+17.09%

Price vs 200+25.04%

MA stackbullish

50/200 cross—

Supertrendup · 14.94

RSI (14)73

MACD hist0.43

MACD cross—

Stoch %K / %D84 / 87

ADX (14)30

+DI / −DI36 / 9

RSI divergence—

MACD divergence—

ATR %+5.39%

ADR %6.32%

52w high18.36

52w low6.30

From 52w high-3.10%

Above 52w low+182.38%

New 52w highNo

SqueezeOff

Bollinger width38.99%

%B1.01

Donchian pos84.48%

Donchian high18.74

Donchian low12.62

AVWAP (52w high)17.77

vs AVWAP high+0.13%

AVWAP (52w low)13.06

vs AVWAP low+36.25%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d0.98×

Avg vol (14d)1.72M

Avg vol (20d)1.62M

Avg $ vol (20d)24.33M

Market cap—

RS 3m (vs SPY)+14.31%

RS 6m (vs SPY)+32.30%

RS line new highNo

Trend template8/8

Technical rank90.7

1 week+13.53%

1 month+26.44%

3 months+32.07%

6 months+44.52%

1 year+184.19%

YTD+55.78%

P/E-13.40

P/B7.10

P/S—

P/FCF-15.70

EPS-1.53

Div yield—

ROE-52.99%

ROA-49.30%

Debt/Eq—

Current17.85

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth52.03%

Price target26.29

Target upside50.75%

Analyst ratingBuy

Institutional108.87%

Ent. value1.71B

Revenue0

Net income-41.28M

Gross profit—

Free cash flow-123.48M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out111.19M

Employees136

ListedFri, Jan 7, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank90.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance16.51

Support12.53

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 11
1 scan
→
Breaking out now
Jun 12
1 scan

Congress activity

Disclosed STOCK Act trades in AMLX

All disclosures →

No recent disclosed trades by Congress in AMLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AMLX · 6 buys

Insider	Side	Shares	Value	Traded	Filed
FONTEYNE PAUL R. Director · Stock Option (right to buy) · 2026-06-04	Grant	24.37K	$0	2026-06-04	2026-06-08
Quimi Daphne Director · Stock Option (right to buy) · 2026-06-04	Grant	24.37K	$0	2026-06-04	2026-06-08
Zeiher Bernhardt G Director · Stock Option (right to buy) · 2026-06-04	Grant	24.37K	$0	2026-06-04	2026-06-08
MILNE GEORGE M JR Director · Stock Option (right to buy) · 2026-06-04	Grant	24.37K	$0	2026-06-04	2026-06-08
Firestone Karen Director · Stock Option (right to buy) · 2026-06-04	Grant	24.37K	$0	2026-06-04	2026-06-08
Firestone Karen Director · Common Stock · 2026-05-21	Buy	3.8K	$51K	2026-05-21	2026-05-26

SEC filings

EDGAR filings in AMLX · 1 recent

EDGAR →

8-K8-KThu, Jun 4, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.